OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation
Abstract
The dynamin-related GTPase OPA1 is mutated in autosomal dominant optic atrophy (DOA) (Kjer type), an inherited neuropathy of the retinal ganglion cells. OPA1 is essential for the fusion of the inner mitochondrial membranes, but its mechanism of action remains poorly understood. Here we show that OPA1 has a low basal rate of GTP hydrolysis that is dramatically enhanced by association with liposomes containing negative phospholipids such as cardiolipin. Lipid association triggers assembly of OPA1 into higher order oligomers. In addition, we find that OPA1 can promote the protrusion of lipid tubules from the surface of cardiolipin-containing liposomes. In such lipid protrusions, OPA1 assemblies are observed on the outside of the lipid tubule surface, a protein-membrane topology similar to that of classical dynamins. The membrane tubulation activity of OPA1 is suppressed by GTPγS. OPA1 disease alleles associated with DOA display selective defects in several activities, including cardiolipin association, GTP hydrolysis and membrane tubulation. These findings indicate that interaction of OPA1 with membranes can stimulate higher order assembly, enhance GTP hydrolysis and lead to membrane deformation into tubules.
Additional Information
© The Author 2010. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Received December 17, 2009; Revised February 15, 2010; Accepted February 22, 2010. We thank Dr Kenichi Morigaki (Kobe University, Japan) for advice on liposome preparation. This work was supported by the National Institutes of Health (grant number GM062967 to D.C.C.) and the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (J.E.H.). T.B. was supported by the Japan Society for Promotion of Science (JSPS) with a Post-Doctoral Fellowship for Research Abroad. Funding to pay the Open Access publication charges for this article was provided by the Howard Hughes Medical Institute.Attached Files
Published - Ban2010p10112Hum_Mol_Genet.pdf
Supplemental Material - ddq088_1.pdf
Files
Name | Size | Download all |
---|---|---|
md5:feb39cc7a187fee02e45223a0da4bda4
|
696.4 kB | Preview Download |
md5:4ac6381ef045a4fae72028432eae0cfc
|
413.4 kB | Preview Download |
Additional details
- PMCID
- PMC2865371
- Eprint ID
- 18499
- Resolver ID
- CaltechAUTHORS:20100601-074205594
- NIH
- GM062967
- National Institute of Diabetes and Digestive and Kidney Diseases
- Japan Society for Promotion of Science (JSPS)
- Howard Hughes Medical Institute (HHMI)
- Created
-
2010-06-28Created from EPrint's datestamp field
- Updated
-
2021-11-08Created from EPrint's last_modified field